Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Lilly Gemzar and Taxol accomplished Phase IIIAntineoplastic & immunomodulating agents
Lilly Gemzar Approved in USAAntineoplastic & immunomodulating agents
Dainippon Sumimoto Pharma Gasmotin in Phase IIAlimentary tract & metabolism
Merck Gardasil Approved in USAAnti-infectives for systemic use
Genta Ganite accomplished Phase IIAntineoplastic & immunomodulating agents
Bayer Gamunex expended indication in Phase IINervous system
Bayer Gamunex expended indication in Phase IIINervous system
Bayer Gamunex Approved in USAAntineoplastic & immunomodulating agents
Baxter International GAMMAGARD Liquid Approved in USAAntineoplastic & immunomodulating agents
Novartis Galvus Submitted for approval in EUAlimentary tract & metabolism
AstraZeneca Galida discontinuedAlimentary tract & metabolism
Cephalon Gabitril accomplished Phase IINervous system
Depomed Gabapentin GR accomplished Phase IINervous system
Depomed Gabapentin GR Submitted for approval in USAGenito urinary system & sex hormones
Depomed Furosemide GR accomplished Phase IICardiovascular system
Astellas Pharma Funguard Approved in EU and Japan, Submitted for approval in USAnti-infectives for systemic use
Endo Frova accomplished Phase IIICardiovascular system
Pfizer Fragmin Submitted for approval in USAAntineoplastic & immunomodulating agents
Shire FOSRENOL Approved in US and SwedenAlimentary tract & metabolism
Merck FOSAMAX PLUS D Approved in USAMusculoskeletal system
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.